BioSyent Inc. (BIOYF)
OTCMKTS
· Delayed Price · Currency is USD
8.70
+0.30 (3.57%)
May 19, 2025, 1:23 PM EDT
BioSyent Revenue
BioSyent had revenue of 10.98M CAD in the quarter ending March 31, 2025, with 41.96% growth. This brings the company's revenue in the last twelve months to 38.28M, up 16.55% year-over-year. In the year 2024, BioSyent had annual revenue of 35.03M with 10.89% growth.
Revenue (ttm)
38.28M CAD
Revenue Growth
+16.55%
P/S Ratio
3.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
96.33M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.03M | 3.44M | 10.89% |
Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
BioSyent News
- 3 days ago - BioSyent Inc. (BIOYF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - BioSyent declares CAD 0.05 dividend - Seeking Alpha
- 4 days ago - BioSyent Releases Financial Results for First Quarter 2025 - GlobeNewsWire
- 4 days ago - BioSyent Declares Second Quarter 2025 Dividend - GlobeNewsWire
- 11 days ago - BioSyent Schedules First Quarter Earnings Release for May 15, 2025 - GlobeNewsWire
- 20 days ago - BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 5 weeks ago - BioSyent to Attend Planet MicroCap Showcase - GlobeNewsWire
- 6 weeks ago - BioSyent to Present at LD Micro New York Investor Conference - Newsfile Corp